检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:黄山高 吴月玲 张颖 HUANG Shan′gao;WU Yueling;ZHANG Ying(Department of Obstetrics and Gynecology,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,China)
机构地区:[1]广东医科大学附属医院妇产医学中心,广东湛江524000
出 处:《实用医学杂志》2024年第14期1901-1907,共7页The Journal of Practical Medicine
基 金:广东省自然科学基金项目(编号:2017A030313559)。
摘 要:卵巢癌是对全球女性健康构成重大威胁的疾病之一,在中国,卵巢癌在妇科恶性肿瘤中的复发率和病死率最高。传统治疗对晚期或复发性卵巢癌患者效果有限。最近的研究表明,靶向治疗在卵巢癌的治疗中取得了重要进展。本文将聚焦于国内外卵巢癌靶向治疗的相关研究,探讨其机制、应用、现状及面临的困境,旨在为卵巢癌治疗提供新的思路和方向。Ovarian cancer represents a significant threat to women's health globally,with particularly high recurrence and mortality rates in China's context of gynecological malignancies.The effectiveness of traditional therapeutic approaches for advanced and recurrent ovarian cancer remains quite limited.However,recent studies have highlighted the substantial success of targeted therapies in managing ovarian cancer.This paper delves into both national and international research on ovarian cancer's targeted treatments,examining their mechanisms,applications,current landscape,and the challenges they face.It aims to offer innovative perspectives and directions for ovarian cancer treatment.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.43